ifoxan + mesna injection - Mesna (2gm) + Ifosfamide (NA) medicine

Ifoxan + Mesna Injection: Comprehensive Medicine Guide

No reviews yet
🏭 Alkem Laboratories Ltd 📦 Varies by brand 💊 Allopathy 📅 Updated: Sep 26, 2026
⚠️ Hepatotoxicity Risk ⚠️ Nephrotoxicity Risk 📋 Prescription Required 💊 Generic Available
Medically Reviewed
11 min read
Evidence: Well-established for certain cancers as part of combination chemotherapy.
Reviewed by
SaathiMed Expert Panel | Sep 26, 2026
🩺
Medically Fact-Checked & Clinically Verified by SaathiMed Clinical Review Board
Clinical Reference Standards: CDSCO (Central Drugs Standard Control Organisation), Indian Pharmacopoeia (IP) & WHO | Last Updated: September 2026

When to Call Your Doctor IMMEDIATELY

  • Blood in urine or painful urination
  • Fever, chills, or sore throat (signs of infection)
  • Unusual bleeding or bruising
  • Confusion, drowsiness, hallucinations, or seizures
  • Decreased urine output or swelling in legs
  • Chest pain, shortness of breath, or irregular heartbeat
  • Severe nausea or vomiting that prevents drinking fluids
  • Yellowing of skin or eyes (jaundice)
  • Rash, hives, or swelling of face, lips, or throat

If experiencing severe symptoms, call emergency services immediately.

What is ifoxan + mesna injection used for?

This medicine is a combination of ifosfamide, a chemotherapy drug, and mesna, a protective agent. It is given intravenously by a healthcare professional to treat certain cancers, such as testicular cancer and soft tissue sarcoma. Mesna helps prevent bladder damage caused by ifosfamide. It is not for self-administration and requires close medical monitoring.

  • Generic Name: Mesna (2gm) + Ifosfamide (NA)
  • Manufacturer: Alkem Laboratories Ltd
  • Form: Allopathy
  • Pregnancy Category: Consult doctor
  • Prescription Required: Yes

🇮🇳 ifoxan + mesna injection के बारे में (Hindi Summary)

उपयोग: यह दवा इफोस्फामाइड और मेसना का संयोजन है, जिसका उपयोग कुछ प्रकार के कैंसर जैसे टेस्टिकुलर कैंसर, सॉफ्ट टिश्यू सारकोमा और लिम्फोमा के इलाज के लिए किया जाता है। इफोस्फामाइड कैंसर कोशिकाओं को मारता है, जबकि मेसना मूत्राशय को इफोस्फामाइड के हानिकारक प्रभावों से बचाता है। यह दवा केवल डॉक्टर या प्रशिक्षित स्वास्थ्यकर्मी द्वारा नस में इंजेक्शन के माध्यम से दी जाती है। मरीज को इस दवा को घर पर स्वयं नहीं लेना चाहिए। इलाज के दौरान डॉक्टर नियमित रूप से रक्त की जांच, गुर्दे की कार्यप्रणाली और मूत्र की जांच करते हैं।

साइड इफेक्ट्स: इस दवा के सामान्य दुष्प्रभावों में मतली, उल्टी, भूख न लगना, बालों का झड़ना, थकान और रक्त कोशिकाओं की कमी शामिल हैं। गंभीर दुष्प्रभावों में मूत्राशय में रक्तस्राव, गंभीर संक्रमण, गुर्दे की क्षति, और तंत्रिका तंत्र की समस्याएं जैसे भ्रम, नींद आना या दौरे पड़ना शामिल हैं। अगर पेशाब में खून आए, बुखार हो, सांस लेने में तकलीफ हो, या दिल की धड़कन अनियमित हो, तो तुरंत डॉक्टर से संपर्क करें।

सुरक्षा सलाह: यह दवा केवल अस्पताल या कैंसर केंद्र में प्रशिक्षित डॉक्टर द्वारा दी जानी चाहिए। इसे घर पर स्वयं न लें। इलाज के दौरान भरपूर पानी पिएं ताकि मूत्राशय की रक्षा हो सके। अपने डॉक्टर को पेशाब में खून, पेशाब करते समय दर्द, या पेशाब कम आने की सूचना तुरंत दें। संक्रमण से बचने के लिए हाथ धोते रहें और भीड़-भाड़ वाली जगहों से बचें। इलाज के दौरान गर्भधारण न करें और स्तनपान न कराएं। शराब का सेवन न करें। नियमित जांच के लिए समय पर अस्पताल जाएं।

💡 Did You Know? India has the highest number of USFDA-compliant plants outside the USA.

💊 ifoxan + mesna injection Uses & Benefits

[{"condition":"Testicular cancer","description":"Used as part of combination chemotherapy regimens to treat germ cell tumors of the testis, often in patients who have not responded to other treatments.","evidence":"Well-established"},{"condition":"Soft tissue sarcoma","description":"Employed in the treatment of various soft tissue sarcomas, either alone or in combination with other chemotherapy agents.","evidence":"Well-established"},{"condition":"Non-Hodgkin lymphoma","description":"Used in salvage chemotherapy regimens for relapsed or refractory non-Hodgkin lymphoma.","evidence":"Established"},{"condition":"Hodgkin lymphoma","description":"Included in some combination chemotherapy protocols for advanced or relapsed Hodgkin lymphoma.","evidence":"Established"},{"condition":"Ovarian cancer","description":"Sometimes used in combination chemotherapy for ovarian germ cell tumors or epithelial ovarian cancer.","evidence":"Limited"},{"condition":"Small cell lung cancer","description":"Used in some chemotherapy regimens for extensive-stage small cell lung cancer.","evidence":"Limited"}]

Off-label uses: [{"condition":"Ewing sarcoma","description":"Ifosfamide with mesna may be used off-label as part of combination therapy for Ewing sarcoma family of tumors.","evidence":"Limited"},{"condition":"Osteosarcoma","description":"Occasionally used off-label in combination regimens for osteosarcoma, especially in recurrent disease.","evidence":"Limited"},{"condition":"Thymoma and thymic carcinoma","description":"Off-label use in combination chemotherapy for advanced thymic malignancies.","evidence":"Limited"}]

Primary treatment for: Cancer (various types, including testicular cancer, soft tissue sarcoma, lymphoma)

Also treats: Testicular cancer, Soft tissue sarcoma, Non-Hodgkin lymphoma, Hodgkin lymphoma, Ovarian cancer, Small cell lung cancer

📋 Drug Information

Generic Name(s)Mesna (2gm) + Ifosfamide (NA)
Brand Nameifoxan + mesna injection
ManufacturerAlkem Laboratories Ltd
Packaging / FormVaries by brand (Allopathy)
Therapeutic ClassANTI NEOPLASTICS
Action Class
Route of AdministrationParenteral (intravenous injection or infusion)
StorageStore this medicine in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Keep the vial in its original carton to protect from light. Once reconstituted or diluted, the solution should be used immediately or stored as directed by the manufacturer. Follow the specific storage instructions provided with the product.
Shelf LifeThe shelf life of this medicine is typically 24 months from the date of manufacture when stored under recommended conditions. Refer to the product packaging for the exact expiration date. Do not use after the expiry date.
WHO GuidelineNot established from the available information. Ifosfamide with mesna is included in various international treatment guidelines for specific cancers, but specific WHO recommendations are not available in the provided information.
ICMR GuidelineNot established from the available information. ICMR guidelines for cancer treatment may include ifosfamide with mesna for certain indications, but specific recommendations are not available in the provided information.

👨‍⚕️ Doctor's Practical Tips

Evidence-based practical advice from experienced clinicians

1
Ensure adequate hydration before, during, and after ifosfamide administration to help prevent hemorrhagic cystitis.
2
Administer mesna at the appropriate intervals (typically before ifosfamide and at 4 and 8 hours after) to maximize bladder protection.
3
Monitor complete blood counts closely, as myelosuppression is common and may require dose adjustments or growth factor support.
4
Watch for signs of central nervous system toxicity, especially in patients with renal impairment or low serum albumin, and manage promptly.
5
Check kidney function regularly, as ifosfamide can cause nephrotoxicity, including Fanconi syndrome.
6
Advise patients to avoid alcohol and grapefruit juice during treatment.
7
Discuss fertility preservation options with patients of childbearing potential before starting treatment.
8
Ensure patients use effective contraception during treatment and for at least 6 months after the last dose.

🔍 Is This Medicine Right for Your Symptom?

Educational reference. Always consult a doctor for diagnosis.

✅
Cancer diagnosis (e.g., testicular, sarcoma, lymphoma)
This medicine is prescribed for certain cancers as part of chemotherapy.
Likely Use
❌
Blood in urine
This is a side effect that requires immediate medical attention, not a reason to use this medicine.
Not Primary
❌
Fever
This medicine is not a fever reducer. Fever during treatment may indicate infection and requires urgent evaluation.
Not Primary

🔬 How This Medicine Works (Pharmacology)

Pharmacokinetics

AbsorptionThis medicine is administered intravenously, so absorption is not applicable. Ifosfamide and mesna are directly introduced into the bloodstream, achieving complete bioavailability.
DistributionIfosfamide and its metabolites distribute widely throughout the body, including into the cerebrospinal fluid, though central nervous system penetration is variable. Mesna distributes primarily in the extracellular fluid and is rapidly taken up by the kidneys. Both compounds have relatively small volumes of distribution. Protein binding of ifosfamide is low, and mesna is largely unbound.
Protein BindingIfosfamide is approximately 20% bound to plasma proteins. Mesna is not significantly protein-bound.
MetabolismIfosfamide undergoes extensive hepatic metabolism via cytochrome P450 enzymes, primarily CYP3A4 and CYP2B6, to active and inactive metabolites. The main activation pathway produces 4-hydroxyifosfamide, which leads to isophosphoramide mustard and acrolein. Ifosfamide also undergoes N-dechloroethylation, producing chloroacetaldehyde, which is associated with neurotoxicity. Mesna is metabolized to mesna disulfide, which is reduced back to mesna, and is also excreted unchanged.
Half-LifeThe elimination half-life of ifosfamide is approximately 4 to 15 hours, depending on the patient and dose. Mesna has a terminal elimination half-life of about 1.5 to 2 hours, but its protective effect is maintained by repeated dosing.
ExcretionIfosfamide and its metabolites are primarily excreted in the urine. About 70-80% of a dose is recovered in urine as unchanged drug and metabolites. Mesna is excreted almost entirely in the urine, with about 50% as unchanged mesna and the rest as mesna disulfide.
BioavailabilityIntravenous administration provides 100% bioavailability for both ifosfamide and mesna.
Onset of ActionThe cytotoxic effects of ifosfamide begin after metabolic activation, typically within hours of administration. The protective effect of mesna on the bladder starts as soon as it is excreted in the urine, which occurs within minutes to hours after intravenous administration.
Peak Plasma TimeFollowing intravenous administration, peak plasma concentrations of ifosfamide are reached at the end of the infusion. Mesna reaches peak plasma levels immediately after intravenous injection.
Duration of ActionThe anti-tumor effect of ifosfamide is not directly measurable by a specific duration, as it depends on the treatment regimen and tumor response. The uroprotective effect of mesna lasts for several hours after each dose, which is why it is often given before and after ifosfamide to cover the period of acrolein excretion.

How It Works

Ifosfamide is a prodrug that requires activation by liver enzymes, specifically cytochrome P450 enzymes, to form its active metabolite, 4-hydroxyifosfamide, which then breaks down to acrolein and isophosphoramide mustard. The isophosphoramide mustard acts as an alkylating agent, forming cross-links between DNA strands and causing DNA damage that prevents cancer cells from dividing and leads to cell death. Mesna is a sulfhydryl compound that is rapidly excreted by the kidneys and reacts with acrolein in the urine to form a non-toxic thioether, thereby protecting the bladder lining from acrolein-induced hemorrhagic cystitis. Mesna does not interfere with the anti-tumor activity of ifosfamide.

Mechanism Steps

1
Activation of ifosfamide: Ifosfamide is metabolized in the liver by cytochrome P450 enzymes, primarily CYP3A4 and CYP2B6, to form 4-hydroxyifosfamide, which exists in equilibrium with its tautomer, aldophosphamide.
2
Formation of active alkylating agent: 4-Hydroxyifosfamide spontaneously decomposes to release isophosphoramide mustard, the active alkylating metabolite, and acrolein, a toxic byproduct.
3
DNA cross-linking: Isophosphoramide mustard alkylates DNA at guanine N7 positions, forming interstrand and intrastrand cross-links that block DNA replication and transcription, leading to cancer cell death.
4
Renal excretion of acrolein: Acrolein is filtered by the kidneys and concentrated in the urine, where it can cause irritation and bleeding of the bladder mucosa (hemorrhagic cystitis).
5
Detoxification by mesna: Mesna is excreted in the urine, where it reacts with acrolein to form a stable, non-toxic thioether, thereby protecting the bladder epithelium from damage.

💡 How to Take ifoxan + mesna injection

Strength: This product is a combination pack containing ifosfamide injection and mesna injection. The specific strengths may vary. The composition includes mesna 2 grams and ifosfamide (strength not specified in the provided identity). The dosage form is an injection, and the route is parenteral.

1This medicine is given by a healthcare professional in a hospital or clinic setting. You will not take it at home.
2Before each dose, your doctor will check your blood counts, kidney function, and urine for blood.
3You will receive intravenous fluids to keep you hydrated and help protect your bladder.
4You may receive anti-nausea medicines before the infusion to prevent nausea and vomiting.
5Mesna will be given before and after ifosfamide to protect your bladder from irritation.
6After the infusion, you will be monitored for any reactions.
7Drink plenty of fluids as advised by your doctor to help flush your bladder.
8Report any side effects to your healthcare team immediately.

Dosage Information

Adult DosageThe dose of this medicine is highly individualized and depends on the specific cancer being treated, the treatment regimen, the patient's body surface area, kidney and liver function, and previous treatments. It is given intravenously by a healthcare professional, usually in a hospital or cancer center. A common regimen for ifosfamide is 1.2 to 2.5 grams per square meter of body surface area per day for several days, repeated every 3 to 4 weeks, but this varies widely. Mesna is given at a dose equal to 20% to 100% of the ifosfamide dose, typically before and after ifosfamide, to protect the bladder. Dose must be individualized by a qualified clinician based on indication, age, weight, renal and hepatic function. Never self-administer this medicine.
Pediatric DosagePediatric dosing is not established from available information. Consult a pediatric oncologist for dosing in children. This medicine may be used in children under the supervision of a pediatric oncologist, but the dose must be individualized based on body surface area, tumor type, and other factors.
Elderly DosageElderly patients (65 years and older) may be more sensitive to the toxic effects of this medicine, especially myelosuppression, nephrotoxicity, and neurotoxicity. Doses should be selected with caution, and kidney function should be monitored closely. Dose adjustments may be necessary based on renal function and overall health status.
Renal ImpairmentPatients with renal impairment may require dose reduction. Ifosfamide and its metabolites are excreted by the kidneys, and renal impairment can increase the risk of toxicity, especially neurotoxicity and myelosuppression. Kidney function should be assessed before and during treatment. Dose adjustments should be made by a qualified clinician based on creatinine clearance and clinical status.
Hepatic ImpairmentPatients with hepatic impairment may have altered metabolism of ifosfamide, which could affect efficacy and toxicity. Liver function should be monitored. Dose adjustments may be necessary in patients with severe hepatic impairment. Consult a qualified clinician for individualized dosing.
Maximum Daily DoseThe maximum daily dose is not fixed and depends on the specific treatment protocol. Common regimens may use up to 2.5 grams per square meter per day for several days, but higher doses have been used in some settings. The dose must be determined by a qualified oncologist based on the patient's condition and treatment plan.

Dosage Timeline

🌅 Morning ❌ ☀️ Afternoon ❌ 🌆 Evening ❌ 🌙 Night ❌

🍽️ Food Timing Guide

With food
No specific food restrictions, but eat small, frequent meals if nauseated.
Helps maintain nutrition during treatment.
Grapefruit
Avoid
May inhibit CYP3A4 and increase ifosfamide levels, potentially increasing toxicity.
St. John's wort
Avoid
May induce CYP3A4 and decrease ifosfamide efficacy.
Alcohol
Avoid
May increase liver toxicity and worsen side effects.

⏰ What to Do If You Miss a Dose

📌 You miss a scheduled appointment for your injection
→ Contact your doctor or treatment center immediately to reschedule.
💡 Do not attempt to self-administer this medicine. Your treatment schedule is important for effectiveness.
📌 You are unable to attend your appointment due to illness
→ Inform your doctor as soon as possible. They will advise whether to reschedule or adjust your treatment.
💡 Do not skip doses without medical advice.

⚠️ Side Effects of ifoxan + mesna injection

✅ Common Side Effects

Nausea and vomiting (Common (10-50%))
Your doctor will prescribe anti-nausea medicines before treatment. Take them as directed and inform your doctor if vomiting persists.
Hair loss (alopecia) (Common (50-100%))
Hair loss is temporary and usually grows back after treatment ends. Consider a wig or head covering if desired.
Fatigue (Common (30-60%))
Rest when needed, but try light activity. Report severe fatigue to your doctor.
Loss of appetite (Common (20-40%))
Eat small, frequent meals. Ask about nutritional supplements if needed.
Low blood cell counts (Common (30-70%))
Your doctor will monitor blood counts. Report fever, chills, or unusual bleeding immediately.
Bladder irritation (dysuria, frequency) (Common (10-30%))
Drink plenty of fluids. Mesna helps prevent this. Report blood in urine or severe pain.

🚨 Serious Side Effects

Hemorrhagic cystitis (Uncommon with mesna (<5%))
Seek immediate medical attention if you see blood in your urine, have painful urination, or lower abdominal pain.
Severe bone marrow suppression (neutropenia, thrombocytopenia, anemia) (Common (30-60%))
Report fever, sore throat, easy bruising, or bleeding. Your doctor will monitor blood counts and may adjust treatment.
Central nervous system toxicity (encephalopathy, seizures, coma) (Uncommon (5-20%))
Report confusion, drowsiness, hallucinations, or seizures immediately. This is a medical emergency.
Nephrotoxicity (kidney damage, Fanconi syndrome) (Uncommon (5-10%))
Your doctor will monitor kidney function. Report decreased urination or swelling.
Cardiotoxicity (heart failure, arrhythmias) (Rare (<1%))
Report chest pain, shortness of breath, or irregular heartbeat immediately.
Anaphylaxis (Rare (<0.1%))
Seek emergency help if you experience rash, swelling of face or throat, difficulty breathing, or dizziness.

⚠️ Rare Side Effects

Pulmonary toxicity (interstitial pneumonitis, fibrosis)
Report new or worsening cough, shortness of breath, or fever.
Secondary malignancies
Long-term follow-up is recommended. Report any new lumps or unusual symptoms.
Severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis)
Seek immediate medical attention if you develop a rash, blisters, or peeling skin.
Infertility
Discuss fertility preservation options before starting treatment if applicable.

Consult your doctor if you experience any unusual symptoms.

🔬 Drug Interactions

Drug Severity Effect
Warfarin Major
Cisplatin Major
Live vaccines Major
Rifampin Moderate
Ketoconazole Moderate
Aminoglycosides Moderate
Amphotericin B Moderate
Allopurinol Moderate
Heparin Moderate
Grapefruit juice Minor

🚨 Major Interactions

  • Warfarin
  • Cisplatin
  • Live vaccines
  • CYP3A4 inducers (e.g., rifampin, phenytoin, carbamazepine)
  • CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin)

⚡ Moderate Interactions

  • Aminoglycosides
  • Amphotericin B
  • Allopurinol
  • Anticoagulants (heparin, low molecular weight heparin)

🍷 Alcohol Interaction

Alcohol should be avoided while receiving this medicine. Alcohol can increase the risk of liver toxicity and may worsen nausea, vomiting, and central nervous system side effects. It can also dehydrate you, which is harmful when you need to maintain good urine output to protect your bladder.

🔎 Check Your Other Medicines

Educational tool. Always confirm with your doctor or pharmacist.

🛡️ Safety & Warnings

🚫 Contraindications

["Known hypersensitivity to ifosfamide, mesna, or any component of the formulation","Severe bone marrow suppression (e.g., leukopenia, thrombocytopenia, anemia)","Active urinary tract infection or hemorrhagic cystitis","Severe renal impairment","Severe hepatic impairment","Pregnancy (unless the potential benefit justifies the potential risk to the fetus)","Breastfeeding"]

⚠️ Warnings & Precautions

["This medicine should only be administered by qualified healthcare professionals experienced in cancer chemotherapy.","Hemorrhagic cystitis: Mesna reduces but does not eliminate the risk. Maintain adequate hydration and monitor urine for blood.","Myelosuppression: Monitor blood counts closely. Dose reduction or delay may be necessary.","Central nervous system toxicity: Can be severe and life-threatening. Monitor for confusion, drowsiness, or seizures.","Nephrotoxicity: Monitor kidney function. Avoid concomitant nephrotoxic drugs when possible.","Hepatotoxicity: Monitor liver function. Report jaundice or right upper quadrant pain.","Cardiotoxicity: Rare but serious. Monitor patients with pre-existing heart disease.","Secondary malignancies: Long-term risk of developing secondary cancers.","Fertility: May cause temporary or permanent infertility. Discuss fertility preservation before treatment.","Vaccinations: Avoid live vaccines during treatment.","Pregnancy: May cause fetal harm. Use effective contraception."]

🤱 Lactation Safety

It is not known whether ifosfamide or mesna are excreted in human breast milk. Because of the potential for serious adverse reactions in nursing infants, breastfeeding should be discontinued during treatment with this medicine and for a period after the last dose as advised by the doctor.

💊 Overdose Management

There is no specific antidote for overdose with this medicine. Overdose may cause severe myelosuppression, nephrotoxicity, neurotoxicity, and cardiotoxicity. Management should be symptomatic and supportive, including close monitoring of blood counts, kidney and liver function, and neurological status. Hemodialysis may be considered for ifosfamide removal, but its effectiveness is limited. Mesna does not prevent ifosfamide overdose toxicity. In case of suspected overdose, seek immediate medical attention.

⏰ Missed Dose

This medicine is administered by a healthcare professional in a clinical setting. If you miss an appointment for your scheduled dose, contact your doctor or treatment center immediately to reschedule. Do not attempt to self-administer this medicine. Your treatment schedule is carefully planned, and missing a dose may reduce the effectiveness of your treatment.

Additional Safety Advice

General Safety

This medicine must only be given by a qualified healthcare professional in a properly equipped medical facility. Do not attempt to administer it at home. Before each dose, your doctor will check your blood counts, kidney function, liver function, and urine for blood. You should drink plenty of fluids as advised to help flush your bladder and reduce the risk of bladder irritation. Inform your doctor immediately if you notice blood in your urine, pain or burning while urinating, or a decrease in urine output. Avoid contact with people who have infections, and practice good hand hygiene because your immune system may be weakened. Do not receive any live vaccines while on this medicine without your doctor's approval. Use effective contraception during treatment and for a period after, as this medicine can harm an unborn baby. Avoid alcohol, as it may worsen liver and stomach effects. Do not breastfeed while receiving this medicine. Keep all follow-up appointments for blood tests and monitoring.

👴 Special Considerations for Elderly

💡 For Patients Above 65

Elderly patients may be more susceptible to the toxic effects of this medicine, especially bone marrow suppression, kidney damage, and neurological toxicity. Doses may need to be adjusted based on kidney function and overall health. Close monitoring is essential. Elderly patients should also be assessed for falls risk and other age-related conditions.

🤰 Pregnancy Planning (TTC)

This medicine can cause harm to an unborn baby. Women of childbearing potential should use effective contraception during treatment and for at least 6 months after the last dose. Men should also use contraception during treatment and for at least 3 months after. If you are planning to become pregnant, discuss with your doctor before starting treatment. Fertility preservation options should be considered before treatment begins.

🏥 Post-Surgery Considerations

If you have recently had surgery, inform your surgeon and oncologist before receiving this medicine. It can affect wound healing and increase the risk of bleeding or infection. Your treatment may need to be delayed until you have recovered from surgery. Follow your doctor's advice regarding wound care and activity restrictions.

🦷 Dental Procedures

Before any dental procedure, inform your dentist that you are receiving this medicine. It can increase the risk of bleeding and infection. Your dentist may need to consult with your oncologist before performing any procedure. Good oral hygiene is important during treatment to prevent infections.

💚 Lifestyle Tips for Better Results

🏃
Drink plenty of fluids, especially water, to help protect your bladder.
🥗
Eat a balanced diet with adequate protein and calories to maintain strength.
😴
Get plenty of rest, but try light exercise as tolerated to reduce fatigue.
💧
Avoid crowds and people with infections to reduce infection risk.
🧘
Practice good hand hygiene.
🌞
Use sunscreen and protective clothing when outdoors, as your skin may be more sensitive.
🚭
Avoid alcohol and tobacco.
🥑
Keep all follow-up appointments for monitoring.

🏋️ Exercise Considerations

Light exercise, such as walking, may help reduce fatigue and improve mood, but avoid strenuous activity if you feel weak or have low blood counts. Consult your doctor before starting any exercise program. Avoid activities that may cause bleeding or injury if your platelet count is low.

🥗 Diet Recommendations

Drink at least 8-10 glasses of water daily unless otherwise advised.
Eat small, frequent meals if you have nausea or loss of appetite.
Include protein-rich foods like eggs, lean meat, beans, and dairy.
Avoid raw or undercooked foods to prevent infections.
Avoid grapefruit and grapefruit juice.
Limit alcohol consumption.

💼 Impact on Daily Work & Life

This medicine may cause fatigue, nausea, and other side effects that can affect your ability to work. You may need to take time off during treatment cycles. Discuss your work schedule with your employer and doctor. Avoid driving or operating machinery if you feel drowsy or confused. Your doctor can provide a medical certificate for work adjustments if needed.

🛑 When to Stop This Medicine

Do not stop this medicine without consulting your oncologist. Treatment is usually stopped if the cancer progresses, if severe side effects occur, or if you complete the planned number of cycles. Your doctor will decide when to stop based on your response and tolerance. If you experience severe side effects, contact your doctor immediately; they may adjust or delay treatment.

📅 Long-Term Use Effects

Long-term effects of this medicine may include chronic kidney disease, secondary cancers, infertility, and heart or lung problems. Regular follow-up with your oncologist is important to monitor for these effects. Kidney function, blood counts, and overall health should be checked periodically after treatment ends. Some patients may experience persistent fatigue or neuropathy. Discuss any new or persistent symptoms with your doctor.

🌿 Non-Medicine Approaches

These can complement medicine but do not replace prescribed treatment.

Other chemotherapy regimens

Depending on the cancer type, other chemotherapy drugs or combinations may be used instead of ifosfamide and mesna.

Evidence: Well-established
Targeted therapy

For some cancers, targeted drugs may be an option, but this depends on the specific cancer and its genetic profile.

Evidence: Established for certain cancers
Immunotherapy

Immunotherapy may be used for certain cancers, but it is not a substitute for ifosfamide in all cases.

Evidence: Established for certain cancers

💉 Vaccination Considerations

💉 If You're Getting Vaccinated

Live vaccines should be avoided during treatment with this medicine because of the risk of infection. Inactivated vaccines may be given, but their effectiveness may be reduced due to immunosuppression. Consult your doctor before receiving any vaccine. It is also important that household members are up to date on their vaccinations to reduce the risk of spreading infections.

📦 Storage Guide

✅ DO

Store in refrigerator at 2°C to 8°C (36°F to 46°F)

❌ DON'T

Do not freeze

✅ DO

Keep in original carton to protect from light

❌ DON'T

Do not remove from carton until ready to use

✅ DO

Follow the manufacturer's instructions for storage after reconstitution

❌ DON'T

Do not use if the solution is discolored or contains particles

✅ DO

Keep out of reach of children

❌ DON'T

Do not store in bathroom cabinet

✈️ Traveling with This Medicine

This medicine is administered in a hospital or clinic setting, so travel planning should be coordinated with your treatment schedule. If you need to travel during treatment, discuss with your oncologist. Carry a copy of your prescription and medical records. This medicine is not for self-administration, so you do not need to carry it with you. However, if you are prescribed other medicines, carry them in their original packaging with a prescription. Be aware of time zone changes if your treatment schedule needs adjustment. Always inform your healthcare provider if you are planning to travel.

💰 Cost Analysis & Savings

👥 Real Patient Stories

Educational, anonymized scenarios. Individual results may vary.

👤 A 28-year-old man diagnosed with testicular cancer
He received a combination chemotherapy regimen that included ifosfamide and mesna. The treatment was given in the hospital over several days. He experienced nausea and fatigue but was able to manage with anti-nausea medicines. His doctor monitored his blood counts and kidney function regularly. He was advised to drink plenty of fluids to protect his bladder. After completing treatment, his cancer went into remission.
💡 Lesson: Close monitoring and supportive care are essential during ifosfamide and mesna treatment. Staying hydrated helps prevent bladder complications.
👤 A 45-year-old woman with soft tissue sarcoma
She was treated with ifosfamide and mesna as part of her chemotherapy. She experienced hair loss and low blood counts, which required dose adjustments. Her medical team monitored her closely for bladder and kidney problems. She was advised to avoid alcohol and to use contraception. Despite the side effects, the treatment helped shrink her tumor.
💡 Lesson: Regular monitoring and prompt reporting of side effects allow healthcare providers to manage toxicity and continue effective treatment.

💬 Questions Patients Often Ask

Q: How is this medicine given?

A: This medicine is given as an intravenous injection or infusion by a healthcare professional in a hospital or clinic. It is not for self-administration at home.

Q: How long does treatment last?

A: The duration of treatment depends on your specific cancer, treatment regimen, and response. Your oncologist will determine the number of cycles you need.

Q: What are the most common side effects?

A: Common side effects include nausea, vomiting, hair loss, fatigue, and low blood cell counts. Mesna helps reduce the risk of bladder irritation.

Q: Can I drive after receiving this medicine?

A: You should not drive or operate machinery if you feel drowsy, confused, or fatigued. Ask your doctor for guidance based on your symptoms.

Q: Is this medicine safe during pregnancy?

A: No, this medicine can harm an unborn baby. Women should avoid becoming pregnant during treatment and use effective contraception. Men should also use contraception.

Q: What should I do if I experience blood in my urine?

A: Blood in urine is a serious side effect. Contact your doctor immediately or go to the emergency room.

🤔 Common Patient Concerns

💭 These are the concerns patients most commonly raise

  • Can I take this medicine at home?
  • How long will I need to receive this treatment?
  • Will I lose my hair?
  • Can I work during treatment?
  • Will this medicine affect my fertility?
  • What should I do if I miss a dose?
  • Can I drink alcohol while on this medicine?
  • Is it safe to be around pregnant women while on this medicine?

🛑 Myths vs. Facts

  • Myth: This medicine can be taken at home like a pill.
    Fact: This medicine is an injection that must be given by a healthcare professional in a clinic or hospital setting.
  • Myth: Mesna is a chemotherapy drug that also kills cancer cells.
    Fact: Mesna is not a chemotherapy drug. It is a protective agent that helps prevent bladder damage caused by ifosfamide.
  • Myth: Ifosfamide and mesna cause immediate hair loss after the first dose.
    Fact: Hair loss usually occurs 2-3 weeks after the first dose and is temporary.
  • Myth: You can drink alcohol while on this medicine.
    Fact: Alcohol should be avoided as it can worsen liver toxicity and side effects.

🔄 Alternative Options

Generic Alternatives

  • Ifosfamide injection
  • Mesna injection

Brand Alternatives

  • Ifoxan + Mesna Injection

📊 Comparison with Similar Medicines

[{"medicine":"Ifosfamide + Mesna","class":"Alkylating agent + uroprotective agent","route":"Intravenous","main_use":"Testicular cancer, soft tissue sarcoma, lymphoma","key_side_effects":"Myelosuppression, hemorrhagic cystitis (reduced by mesna), neurotoxicity"},{"medicine":"Cyclophosphamide + Mesna","class":"Alkylating agent + uroprotective agent","route":"Intravenous or oral","main_use":"Lymphoma, breast cancer, leukemia","key_side_effects":"Myelosuppression, hemorrhagic cystitis (reduced by mesna), cardiotoxicity"},{"medicine":"Doxorubicin","class":"Anthracycline","route":"Intravenous","main_use":"Breast cancer, sarcoma, lymphoma","key_side_effects":"Cardiotoxicity, myelosuppression, nausea"}]

😊 Was this information helpful?

Browse Medicines A-Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Back to Medicines Directory